Dimensional Fund Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-773,286
| Closed | -$71.9M | – | 3594 |
|
|
2021
Q4 | $71.9M | Buy |
773,286
+112,839
| +17% | +$7.43M | 0.02% | 1143 |
|
|
2021
Q3 | $39.3M | Sell |
660,447
-133,079
| -17% | -$7.86M | 0.01% | 1585 |
|
|
2021
Q2 | $54.1M | Buy |
793,526
+60,943
| +8% | +$3.97M | 0.02% | 1383 |
|
|
2021
Q1 | $50.8M | Buy |
732,583
+75,259
| +11% | +$5.79M | 0.02% | 1434 |
|
|
2020
Q4 | $50.5M | Sell |
657,324
-52,633
| -7% | -$3.95M | 0.02% | 1360 |
|
|
2020
Q3 | $53.1M | Sell |
709,957
-1,327
| -0.2% | -$88.5K | 0.02% | 1148 |
|
|
2020
Q2 | $44.8M | Buy |
711,284
+70,519
| +11% | +$3.88M | 0.02% | 1286 |
|
|
2020
Q1 | $26.9M | Sell |
640,765
-9,560
| -1% | -$438K | 0.01% | 1554 |
|
|
2019
Q4 | $29.5M | Sell |
650,325
-95,033
| -13% | -$4.49M | 0.01% | 1830 |
|
|
2019
Q3 | $34.1M | Buy |
745,358
+155,452
| +26% | +$8.74M | 0.01% | 1706 |
|
|
2019
Q2 | $34.6M | Buy |
589,906
+83,777
| +17% | +$4.33M | 0.01% | 1734 |
|
|
2019
Q1 | $22.7M | Sell |
506,129
-24,353
| -5% | -$1.12M | 0.01% | 1976 |
|
|
2018
Q4 | $20.7M | Buy |
530,482
+170,954
| +48% | +$6.71M | 0.01% | 1957 |
|
|
2018
Q3 | $16.5M | Buy |
+359,528
| New | +$14.6M | 0.01% | 2218 |
|
|
2013
Q4 | – | Sell |
-40
| Closed | -$2K | – | 3544 |
|
|
2013
Q3 | $2K | Sell |
40
-80
| -67% | -$5.37K | ﹤0.01% | 3568 |
|
|
2013
Q2 | $9K | Buy |
+120
| New | +$9.8K | ﹤0.01% | 3534 |
|
Dimensional Fund Advisors's ARNA Position: Q1 2022 in Review
Dimensional Fund Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 773,286 shares — an estimated $71.9M sold.
Dimensional Fund Advisors first reported a position in ARNA in Q2 2013 and held it in 16 quarters. The position peaked at $71.9M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Dimensional Fund Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Dimensional Fund Advisors sold 773,286 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $71.9M.
- Dimensional Fund Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 16 quarters.
- Dimensional Fund Advisors's Arena Pharmaceuticals Inc position peaked at $71.9M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Dimensional Fund Advisors's 13F filing for Q1 2022, filed 13 May 2022.